...
首页> 外文期刊>Journal of Neuropathology and Experimental Neurology >[alpha]B-Crystallin Is a Target for Adaptive Immune Responses and a Trigger of Innate Responses in Preactive Multiple Sclerosis Lesions
【24h】

[alpha]B-Crystallin Is a Target for Adaptive Immune Responses and a Trigger of Innate Responses in Preactive Multiple Sclerosis Lesions

机译:αB-晶体蛋白是主动多发性硬化病灶中适应性免疫反应的目标和先天反应的触发因素

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We present the first comparative analysis of serum immunoglobulin G reactivity profiles against the full spectrum of human myelin-associated proteins in multiple sclerosis patients and healthy control subjects. In both groups, serum antibodies display a consistent and prominent reaction to alphaB-crystallin (CRYAB) versus other myelin proteins. As an apparently major target for the adaptive immune system in humans, CRYAB selectively accumulates in oligodendrocytes, but not in astrocytes, or axons in so-called preactive multiple sclerosis lesions. These are clusters of activated HLA-DR-expressing microglia in myelinated normal-appearing white matter with no obvious leukocyte infiltration. They are found in most multiple sclerosis patients at all stages of disease. In these lesion areas, CRYAB in oligodendrocytes may come directly in contact with activated HLA-DR+ microglia. We demonstrate that CRYAB activates innate responses by microglia by stimulating the secretion of leukocyte-recruiting factors, including tumor necrosis factor, interleukin 17, CCL5, and CCL1, and immune-regulatory cytokines such as interleukin 10, transforming growth factor-beta, and interleukin 13. Together, these data suggest that CRYAB accumulation in preactive lesions may be part of a reversible reparative local response that involves both oligodendrocytes and microglia. At the same time, however, accumulated CRYAB may represent a major target for adaptive immune responses that could contribute to progression of preactive lesions to a stage of demyelination.
机译:我们提出了针对多发性硬化症患者和健康对照组中人髓磷脂相关蛋白全谱的血清免疫球蛋白G反应性谱的首次比较分析。在两组中,血清抗体对αB-晶状体蛋白(CRYAB)相对于其他髓磷脂蛋白均表现出一致且突出的反应。作为人类适应性免疫系统的一个主要目标,CRYAB有选择地积聚在少突胶质细胞中,而不是积聚在星形胶质细胞或所谓的活动性多发性硬化病病变的轴突中。这些是活化的表达HLA-DR的小胶质细胞聚集在有髓的正常外观白质中,没有明显的白细胞浸润。在疾病的所有阶段的大多数多发性硬化症患者中都发现了它们。在这些病变区域,少突胶质细胞中的CRYAB可能会直接与活化的HLA-DR +小胶质细胞接触。我们证明CRYAB通过刺激白细胞刺激因子(包括肿瘤坏死因子,白介素17,CCL5和CCL1)和免疫调节细胞因子(如白介素10,转化生长因子-β和白介素)的分泌来激活小胶质细胞的先天应答。 13.总的来说,这些数据表明CRYAB在活动性病变中的积累可能是涉及少突胶质细胞和小胶质细胞的可逆修复局部反应的一部分。但是,与此同时,累积的CRYAB可能代表了适应性免疫反应的主要目标,该反应可能有助于将反应性病变发展到脱髓鞘阶段。

著录项

  • 来源
  • 作者单位

    Johannes M. van Noort, PhD, Malika Bsibsi, PhD, Wouter H. Gerritsen, Paul van der Valk, MD, Jeffrey J. Bajramovic, PhD, Lawrence Steinman, MD, and Sandra Amor, PhDFrom the TNO Quality of Life (JMVN, MB), Delta Crystallon BV (JMVN, MB), Leiden, Department of Pathology (WHG, PVDV, SA), VU University Medical Centre, Amsterdam, Alternatives Unit (JJB), Biomedical Primate Research Institute, Rijswijk, The Netherlands, Department of Neurology and Neurological Sciences (LS), Beckman Center, Stanford University, Stanford, California, and Neuroscience Centre (SA), Queen Mary University, London, United Kingdom.Send correspondence and reprint requests to: Johannes M. van Noort, PhD, Delta Crystallon BV, Zernikedreef 9, 2333 CK, Leiden, The Netherlands, E-mail: hans@deltacrystallon.comThis study was financially supported by Delta Crystallon BV and the Netherlands Foundation for the support of multiple sclerosis research.Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.jneuropath.com).,;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号